| Overall (n = 1318) | Repro-Endo (n = 187) | OB-Gyn (n = 1131) | P-value |
---|---|---|---|---|
Sex | ||||
 female | 1282 (97.3) | 177 (94.7) | 1105 (97.7) | .018 |
 male | 36 (2.7) | 10 (5.3) | 26 (2.3) | .018 |
Age | ||||
 18–35 | 226 (17.1) | 22 (11.7) | 204 (18.0) | .035 |
 36–45 | 514 (39.0) | 76 (40.7) | 438 (38.7) | NS |
 ≥ 46 | 578 (43.9) | 89 (47.6) | 489 (43.3) | NS |
Hospital grade | ||||
 3 | 793 (60.2) | 123 (65.8) | 670 (59.2) | NS |
 2 | 456 (34.6) | 61 (32.6) | 395 (34.9) | NS |
 1 | 69 (5.2) | 3 (1.6) | 66 (5.9) | .016 |
No. of patients with PCOS treated annually | ||||
 < 50 | 849 (64.4) | 54 (28.8) | 795 (70.3) | <.001 |
 51–200 | 358 (27.2) | 86 (46.0) | 272 (24.0) | <.001 |
 > 200 | 111 (8.4) | 47 (25.2) | 64 (5.7) | <.001 |
Main reason for clinic attendance in patients with PCOS | ||||
 Menstrual disorders | 1062 (80.6) | 130 (69.5) | 932 (82.4) | <.001 |
 Infertility | 226 (17.1) | 54 (29.0) | 172 (15.2) | <.001 |
 Hirsutism/acne | 9 (0.7) | 1 (0.5) | 8 (0.7) | NS |
 Obesity/IR | 21 (1.6) | 2 (1.0) | 19 (1.7) | NS |
Estimated national prevalence of overweight/obesity in patients with PCOS | ||||
 0–30% | 384 (29.1) | 28 (15.0) | 356 (31.5) | <.001 |
 31–50% | 541 (41.1) | 87 (46.5) | 454 (40.1) | NS |
 51–80% | 331 (25.1) | 64 (34.2) | 267 (23.6) | .002 |
 > 80% | 62 (4.7) | 8 (4.3) | 54 (4.8) | NS |